--- title: "12 Health Care Stocks Moving In Tuesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/277658853.md" description: "In Tuesday's intraday session, Edesa Biotech (EDSA) shares surged 61% to $3.67, while NeuroOne Medical Tech (NMTC) rose 15.92% to $0.77. Other gainers included CalciMedica (CALC) up 13.13%, BeyondSpring (BYSI) up 11.67%, and P3 Health Partners (PIII) up 10.87%. Conversely, Iterum Therapeutics (ITRM) plummeted 46.1% to $0.15, SCWorx (WORX) fell 28.44%, and MAIA Biotechnology (MAIA) dropped 28.02%. Theravance Biopharma (TBPH) and Nuvation Bio (NUVB) also saw significant declines of 26.02% and 25.78%, respectively." datetime: "2026-03-03T17:05:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277658853.md) - [en](https://longbridge.com/en/news/277658853.md) - [zh-HK](https://longbridge.com/zh-HK/news/277658853.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Intraday Session ### Gainers - **Edesa Biotech** (NASDAQ:EDSA) shares rose 61.0% to $3.67 during Tuesday's regular session. The company's market cap stands at $19.0 million. - **NeuroOne Medical Tech** (NASDAQ:NMTC) shares moved upwards by 15.92% to $0.77. The company's market cap stands at $33.7 million. - **CalciMedica** (NASDAQ:CALC) stock rose 13.13% to $0.57. The company's market cap stands at $7.3 million. As per the news, the Q4 earnings report came out today. - **BeyondSpring** (NASDAQ:BYSI) stock rose 11.67% to $1.53. The company's market cap stands at $56.3 million. - **P3 Health Partners** (NASDAQ:PIII) shares increased by 10.87% to $2.4. The company's market cap stands at $7.0 million. - **Insight Molecular** (NASDAQ:IMDX) stock increased by 10.52% to $5.46. The market value of their outstanding shares is at $141.6 million. ### Losers - **Iterum Therapeutics** (NASDAQ:ITRM) stock declined by 46.1% to $0.15 during Tuesday's regular session. The company's market cap stands at $14.9 million. - **SCWorx** (NASDAQ:WORX) shares fell 28.44% to $0.23. The market value of their outstanding shares is at $5.1 million. - **MAIA Biotechnology** (AMEX:MAIA) stock fell 28.02% to $1.49. The company's market cap stands at $76.6 million. - **Theravance Biopharma** (NASDAQ:TBPH) stock declined by 26.02% to $14.02. The company's market cap stands at $960.2 million. - **Nuvation Bio** (NYSE:NUVB) stock decreased by 25.78% to $4.33. The market value of their outstanding shares is at $1.9 billion. The company's, Q4 earnings came out yesterday. - **Harrow** (NASDAQ:HROW) shares declined by 23.96% to $40.75. The company's market cap stands at $1.9 billion. As per the news, the Q4 earnings report came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [CALC.US](https://longbridge.com/en/quote/CALC.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [NMTC.US](https://longbridge.com/en/quote/NMTC.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ITRM.US](https://longbridge.com/en/quote/ITRM.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [PIII.US](https://longbridge.com/en/quote/PIII.US.md) - [MAIA.US](https://longbridge.com/en/quote/MAIA.US.md) - [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [TBPH.US](https://longbridge.com/en/quote/TBPH.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [NUVB.US](https://longbridge.com/en/quote/NUVB.US.md) - [ITRMF.US](https://longbridge.com/en/quote/ITRMF.US.md) ## Related News & Research - [Nuvation Bio (NUVB) Gains Fast Track Backing As Fair Value Stays In Focus](https://longbridge.com/en/news/296701962.md) - [Analyst Justin Walsh Reiterates Buy on NeuroOne, Maintains $8 Target on Partner-Driven RF Ablation Growth and Pipeline Upside](https://longbridge.com/en/news/296260661.md) - [Centric Wealth Management Takes Position in MAIA Biotechnology, Inc. $MAIA](https://longbridge.com/en/news/296017785.md) - [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md) - [BeyondSpring posts investor deck highlighting plinabulin late-stage NSCLC program and immune-modulating approach](https://longbridge.com/en/news/296010507.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**